GlassScriptPhysician profile
Michael D Staudt
NPI 1184173858
$138,797.09
in general payments reported to CMS, 2019-2025
32 companies · $9,028 in 2025
The $9,028 reported for 2025 was more than what 85% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2020: $613 · 2021: $3,967 · 2022: $13K · 2023: $15K · 2024: $57K · 2025: $9,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Consulting Fee: $15K · Food and Beverage: $13K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $12K · Travel and Lodging: $6,994 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34,075.00 |
| Consulting Fee | $14,700.00 |
| Food and Beverage | $13,193.64 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $11,900.00 |
| Travel and Lodging | $6,994.04 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $58,907.42 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Spectra Wavewriter |
| Nevro Corp. | $32,954.33 | 2020-2024 | Senza, Vyrsa V1 |
| Medtronic USA, INC. | $15,069.26 | 2019-2020 | |
| Medtronic, INC. | $9,359.34 | 2021-2025 | Synchromedii, Stealthstation S8 Platform, Intellis Adaptivestim |
| Abbott Laboratories | $7,511.25 | 2021-2025 | Proclaim, Eterna, Infinity |
| Zimmer Biomet Holdings, INC. | $6,345.06 | 2022-2024 | Rosa |
| Curonix LLC | $2,349.21 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $1,623.33 | 2024-2025 | Senza, Excelsius Gps, Excelsius3d Imaging System |
| Mml US, INC. | $1,054.39 | 2022-2025 | Reactiv8 |
| Stryker Corporation | $564.35 | 2021-2025 | Duramatrix, Adherus Autospray Et Dural Sealant, Adherus Autospray Dural Sealant |
| Monteris Medical Corporation | $541.75 | 2024 | Neuroblate |
| Neuropace, INC. | $529.35 | 2022-2025 | |
| Sk Life Science, INC. | $362.87 | 2024-2025 | |
| Depuy Synthes Sales INC. | $286.11 | 2022-2025 | Matrixneuro, Cranioplastic, Synthecel |
| Saluda Medical Americas, INC. | $225.16 | 2024 | Evoke |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $175.30 | 2021 | |
| Surgalign Spine Technologies, INC. | $148.98 | 2021 | |
| Telix Pharmaceuticals | $112.12 | 2025 | Illuccix |
| Insightec,INC | $92.40 | 2023-2024 | Exablate |
| Stimwave Technologies Incorporated | $81.73 | 2022 | |
| Spr Therapeutics, INC | $72.76 | 2021-2025 | Sprint Pns System |
| Cerapedics INC. | $66.00 | 2022 | |
| Amneal Pharmaceuticals LLC | $56.80 | 2022 | |
| Livanova USA, INC. | $52.73 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Integra Lifesciences Corporation | $52.33 | 2024-2025 | Codman Hakim, Codman Certas, Cusa Clarity |
| Neuroone Medical Technologies Corporation | $47.65 | 2025 | |
| Ethicon US, LLC | $47.61 | 2025 | Surgiflo Hemostatic Matrix |
| Innovasis INC | $41.33 | 2022 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Astrazeneca Pharmaceuticals LP | $19.46 | 2022 | |
| Spineology INC. | $14.14 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.57 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Staudt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.